MEI Pharma (MEIP)
(Delayed Data from NSDQ)
$3.11 USD
-0.07 (-2.20%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $3.13 +0.02 (0.64%) 7:44 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/24/24 |
---|---|
Current Quarter | -1.42 |
EPS Last Quarter | -1.37 |
Last EPS Surprise | 0.72% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.22 |
Next Year | -5.10 |
EPS (TTM) | 3.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 65.29M | 12.50M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 65.29M | 12.50M |
Low Estimate | NA | NA | 65.29M | 12.50M |
Year ago Sales | 1.46M | 65.30M | 48.82M | 65.29M |
Year over Year Growth Est. | NA | NA | 33.75% | -80.85% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.42 | -1.70 | 3.22 | -5.10 |
# of Estimates | 2 | 1 | 1 | 1 |
Most Recent Consensus | -1.35 | -1.70 | NA | NA |
High Estimate | -1.35 | -1.70 | 3.22 | -5.10 |
Low Estimate | -1.48 | -1.70 | 3.22 | -5.10 |
Year ago EPS | -1.51 | 8.46 | -5.02 | 3.22 |
Year over Year Growth Est. | 5.96% | -120.09% | 164.14% | -258.39% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | -1.42 | -1.70 | 3.22 | -5.10 |
7 Days Ago | -1.42 | -1.70 | 3.22 | -5.10 |
30 Days Ago | -1.42 | -1.70 | 3.22 | -5.10 |
60 Days Ago | -1.42 | -1.70 | 3.22 | -5.10 |
90 Days Ago | -1.42 | -1.70 | 3.22 | -5.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.42 | -1.70 | 3.22 | -5.10 |
Zacks Consensus Estimate | -1.42 | -1.70 | 3.22 | -5.10 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.37 | -1.66 | 8.46 | -1.51 | NA |
Estimate | -1.38 | -1.46 | -1.47 | -3.25 | NA |
Difference | 0.01 | -0.20 | 9.93 | 1.74 | 2.87 |
Surprise | 0.72% | -13.70% | 675.51% | 53.54% | 179.02% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more